To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves Elan's Prialt

FDA approved ELN's Prialt ziconotide intrathecal infusion to treat severe chronic pain. In

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE